These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30097286)

  • 1. Type 3 cytokines in liver fibrosis and liver cancer.
    Molina MF; Abdelnabi MN; Fabre T; Shoukry NH
    Cytokine; 2019 Dec; 124():154497. PubMed ID: 30097286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
    Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
    Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation.
    Radaeva S; Sun R; Pan HN; Hong F; Gao B
    Hepatology; 2004 May; 39(5):1332-42. PubMed ID: 15122762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 3 cytokines IL-17A and IL-22 drive TGF-β-dependent liver fibrosis.
    Fabre T; Molina MF; Soucy G; Goulet JP; Willems B; Villeneuve JP; Bilodeau M; Shoukry NH
    Sci Immunol; 2018 Oct; 3(28):. PubMed ID: 30366940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Role of Interleukins for the Assessment and Treatment of Liver Diseases.
    Ali AL; Nailwal NP; Doshi GM
    Endocr Metab Immune Disord Drug Targets; 2022; 22(4):371-382. PubMed ID: 34819013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
    Li H; Huang MH; Jiang JD; Peng ZG
    World J Gastroenterol; 2018 Dec; 24(47):5297-5311. PubMed ID: 30598575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
    Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
    Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Interleukin-22 in chronic liver injury.
    Carmo RF; Cavalcanti MSM; Moura P
    Cytokine; 2017 Oct; 98():107-114. PubMed ID: 27816383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMP-1 expression induced by IL-32 is mediated through activation of AP-1 signal pathway.
    Xu H; Zhang S; Pan X; Cao H; Huang X; Xu Q; Zhong H; Peng X
    Int Immunopharmacol; 2016 Sep; 38():233-7. PubMed ID: 27302771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-20 and IL-20R1 antibodies protect against liver fibrosis.
    Chiu YS; Wei CC; Lin YJ; Hsu YH; Chang MS
    Hepatology; 2014 Sep; 60(3):1003-14. PubMed ID: 24763901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
    Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
    J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer T cells in liver injury, inflammation and cancer.
    Wang H; Yin S
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1077-85. PubMed ID: 26068039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
    Faggioli F; Palagano E; Di Tommaso L; Donadon M; Marrella V; Recordati C; Mantero S; Villa A; Vezzoni P; Cassani B
    Hepatology; 2018 May; 67(5):1970-1985. PubMed ID: 29105104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions.
    Zekri AN; El Deeb S; Bahnassy AA; Badr AM; Abdellateif MS; Esmat G; Salama H; Mohanad M; El-Dien AE; Rabah S; Abd Elkader A
    World J Gastroenterol; 2018 Mar; 24(11):1228-1238. PubMed ID: 29568203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-38 alleviates concanavalin A-induced liver injury in mice.
    Yuan X; Li Y; Pan X; Peng X; Song G; Jiang W; Gao Q; Li M
    Int Immunopharmacol; 2016 Nov; 40():452-457. PubMed ID: 27723569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonorchis sinensis lysophospholipase A upregulates IL-25 expression in macrophages as a potential pathway to liver fibrosis.
    Zhou L; Shi M; Zhao L; Lin Z; Tang Z; Sun H; Chen T; Lv Z; Xu J; Huang Y; Yu X
    Parasit Vectors; 2017 Jun; 10(1):295. PubMed ID: 28623940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
    Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z
    J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice.
    Nakamoto N; Amiya T; Aoki R; Taniki N; Koda Y; Miyamoto K; Teratani T; Suzuki T; Chiba S; Chu PS; Hayashi A; Yamaguchi A; Shiba S; Miyake R; Katayama T; Suda W; Mikami Y; Kamada N; Ebinuma H; Saito H; Hattori M; Kanai T
    Cell Rep; 2017 Oct; 21(5):1215-1226. PubMed ID: 29091761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?
    Hammad LN; Abdelraouf SM; Hassanein FS; Mohamed WA; Schaalan MF
    J Immunotoxicol; 2013; 10(4):380-6. PubMed ID: 23350952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.